Shelton Wealth Management LLC Purchases 273 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Shelton Wealth Management LLC raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.7% in the fourth quarter, Holdings Channel reports. The firm owned 4,359 shares of the exchange traded fund’s stock after acquiring an additional 273 shares during the quarter. Shelton Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $393,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. FMR LLC increased its position in shares of SPDR S&P Biotech ETF by 13.6% during the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after acquiring an additional 830 shares in the last quarter. Beaton Management Co. Inc. purchased a new stake in SPDR S&P Biotech ETF during the 3rd quarter valued at $212,000. Prairie Wealth Advisors Inc. raised its stake in shares of SPDR S&P Biotech ETF by 3.6% in the second quarter. Prairie Wealth Advisors Inc. now owns 6,616 shares of the exchange traded fund’s stock worth $613,000 after purchasing an additional 231 shares during the last quarter. Robinson Value Management Ltd. raised its stake in shares of SPDR S&P Biotech ETF by 1.2% in the third quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock worth $1,329,000 after purchasing an additional 155 shares during the last quarter. Finally, Envestnet Asset Management Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 12.5% during the second quarter. Envestnet Asset Management Inc. now owns 186,400 shares of the exchange traded fund’s stock valued at $17,281,000 after purchasing an additional 20,685 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $87.97 on Friday. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The business’s fifty day moving average is $94.09 and its 200 day moving average is $96.90. The stock has a market capitalization of $6.71 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.